메뉴 건너뛰기




Volumn 58, Issue 2 SUPPL. 1, 2001, Pages 78-82

Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer

Author keywords

[No Author keywords available]

Indexed keywords

FLUTAMIDE; GOSERELIN; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

EID: 0034909873     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01246-8     Document Type: Conference Paper
Times cited : (14)

References (5)
  • 1
    • 0004409499 scopus 로고    scopus 로고
    • Pilepich MV, Caplan R, Byhardt RW, et al: Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of radiation therapy oncology group protocol 85-31. J Clin Oncol 15: 1013-1021, 1997.
  • 2
    • 0004415769 scopus 로고    scopus 로고
    • Pilepich MV, Winter K, Roach M, et al: Phase III radiation therapy oncology group (RTOG) 86-10 of androgen deprivation before and during radiotherapy in locally advanced carcinoma of the prostate [abstract]. J Clin Oncol 17: 308a, 1998, Abstract 1185.
  • 4
    • 0004444494 scopus 로고    scopus 로고
    • Hanks GE, Lu J, Machtay M, et al: RTOG Protocol 92-02: a phase III trial of the use of long term androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy for locally advanced carcinoma of the prostate. Proceedings of American Society of Clinical Oncology 2000 [abstract]. J Clin Oncol 19: 327a, 2000, Abstract 1284.
  • 5
    • 0004447523 scopus 로고    scopus 로고
    • D'Amico AV, Schultz D, Loffredo M, et al: Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for men with clinically localized prostate cancer. JAMA 284: 1280-1283, 2000.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.